CTNBio's analysis focuses on the "Badger G" variety, which prioritizes industrial use and high levels of cannabigerol (CBG)

Companies report delays in shipments clearance, while official data from Anvisa indicate reduced average deadlines and a high approval rate

Neurosurgeon explains on the Deusa Cast podcast how cannabis works on pain, mood, and multiple symptoms, functioning as a multifunctional therapeutic tool

Associations question the exclusivity of dispensing in hospitals provided for in the new Royal Decree; deadline for defining clinical uses by the regulatory agency expired in early January

Unanimous decision of the 3rd Public Law Chamber benefits woman, the rapporteur cites criteria of the STJ

Driven by sustainable demands, the hempcrete market projects an annual growth rate of 3.86% over the next decade, despite regulatory challenges

Driven by sustainable demands, the hempcrete market projects an annual growth rate of 3.86% over the next decade, despite regulatory challenges

Partnership with TWA Brands foresees early purchase of products registered with Anvisa and marks the entry of the European company into Brazil

Ana Gabriela Batista demands, during industry congress, guidelines that facilitate treatments and ensure legal certainty

While the global index declines, the ETF MSOS accumulates significant gains in 2025, driven by expectations of changes in Section 280E

Commercial mission foresees technical cooperation, technology transfer, and investments for the development of the Ghanaian cannabis sector

Amidst the expansion of the medical market, regulatory tensions, and the entry of emerging countries like Brazil, the conference solidifies as a strategic space for scenario reading, political articulation, and global business

Financial contributions from major companies in the sector occurred months before the president's executive measure, aiming for a change in federal legislation

Financial consolidation, cultivation regulation, and strengthening of events mark the sector's prospects for the next year

Initiative in the Limpopo province tests national hemp genetics to boost rural and economic development

Bill on medicinal cannabis in Germany enters a decisive phase in Parliament and receives warnings from experts about regulatory and implementation challenges

A scientific review highlights the lack of robust evidence on medicinal cannabis and reinforces the need for more rigorous and balanced research in the field

According to dentist Cynthia De Carlo, studies indicate that cannabidiol may offer effective analgesia after tooth extractions, especially for patients with restrictions to traditional analgesics

Agency presents new report without a defined timeline, while experts warn that a change to Schedule III would have profound impacts on research and taxation, but not federal legalization

New legislation establishes clear limits for adult use, differentiates administrative infractions from crimes, and standardizes legal criteria on cannabis

Located in the South Pacific, New Caledonia has presented a legislative proposal to structure a regulated tropical hemp sector by 2030, with rules for cultivation, processing, and sanitary control

Minister Guilherme Boulos meets sector to discuss working group and inclusion of associations in new medicinal cannabis legislation

In an interview with Deusa Cast, Beto Brant analyzes the role of patient associations and compares the medical cannabis models of Brazil and Uruguay

In a study, a Dutch university reveals how cannabis developed the ability to produce THC, CBD, and CBC through the evolution of ancestral enzymes

Study maps the DNA of six distinct cultivars' chloroplast, revealing promising genetic tools for crop improvement and forensic tracking

Florida Attorney General's request to the Supreme Court seeks to prevent the cannabis legalization proposal from being included on the 2026 ballot

Meeting at the Planalto, with the presence of Eduardo Suplicy, discusses the recognition of associations and access to treatment

Research published reveals that the combined use of cannabinoids interrupts the cell cycle and induces the death of tumor cells while preserving healthy tissues.

The DEA has increased the legal quotas for the production of psychedelics such as psilocybin and DMT for 2026, focusing on scientific and medical research in the United States.

New regulations came into effect on January 1 focusing on taxes and enforcement